American Century Companies’s Recursion Pharmaceuticals RXRX Stock Holding History

American Century Companies's RXRX Position: Q2 2026 in Review

American Century Companies increased its Recursion Pharmaceuticals (RXRX) stake by 31% in Q2 2026, buying an estimated $321K and bringing the position to 406,774 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2295.

American Century Companies first reported a position in RXRX in Q3 2021 and has held it in 11 quarters since. The position peaked at $5.19M in Q4 2021. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

• American Century Companies held 406,774 shares of Recursion Pharmaceuticals worth $1.49M as of Q2 2026.
• American Century Companies bought 96,340 Recursion Pharmaceuticals shares in Q2 2026, an estimated $321K.
• Recursion Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2295 holding.
• American Century Companies first reported a position in Recursion Pharmaceuticals in Q3 2021 and has held it in 11 quarters since.
• American Century Companies's Recursion Pharmaceuticals position peaked at $5.19M in Q4 2021.
• 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.